ITGB3 and cancer: We found that the cancer-specific WT CD61+ T cell clone had significantly elevated expression of a cytolytic degranulation marker, CD107a, compared to the T cells treated with CD61 siRNA, CD61KO and the WT CD61− T cell clones (Fig. 4a).